Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC
Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Open Exploration Publishing Inc.
2026-04-01
|
| Серія: | Exploration of Targeted Anti-tumor Therapy |
| Предмети: | |
| Онлайн доступ: | https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|